Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 4 Study of Effects of ARB Compared With Diuretics in Hypertension Patients With High Cardiovascular Risks.

Next Previous
Trial Profile

Phase 4 Study of Effects of ARB Compared With Diuretics in Hypertension Patients With High Cardiovascular Risks.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Sep 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amiloride (Primary) ; Amlodipine (Primary) ; Hydrochlorothiazide/amiloride (Primary) ; Simvastatin (Primary) ; Telmisartan (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms CHIEF

Most Recent Events

  • 17 Jun 2013 Four year results presented at the 23rd European Meeting on Hypertension.
  • 04 Oct 2012 Final results at 4 years presented at the 24th Scientific Meeting of the International Society of Hypertension.
  • 10 Aug 2012 Planned End Date changed from 1 Dec 2013 to 1 Dec 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top